Salivary Gland Cancer – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Salivary Gland Cancer – Drugs In Development, 2024 report and make more profitable business decisions.
Salivary gland cancer refers to malignant tumors that develop in the tissues of the salivary glands, which produce saliva to aid in digestion and maintain oral health. These glands are located in various areas of the mouth and throat, including the parotid glands (the largest salivary glands), submandibular glands, sublingual glands, and numerous minor glands throughout the mouth.
Salivary gland cancers can be classified into different types based on the specific cells they originate from, including mucoepidermoid carcinoma, adenoid cystic carcinoma, acinic cell carcinoma, and adenocarcinoma.
The Salivary Gland Cancer drugs in development market research report provide comprehensive information on the therapeutics under development for Salivary Gland Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Salivary Gland Cancer and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Salivary Gland Cancer | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 55 molecules, with 53 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Salivary Gland Cancer therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Salivary Gland Cancer pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Salivary Gland Cancer treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Actuate Therapeutics IncAkamis Bio Ltd
Alphamab Oncology
Ambrx Biopharma Inc
Ascentage Pharma Group International
AstraZeneca Plc
Bayer AG
Beijing Scitech-MQ Pharmaceuticals Ltd
Bristol-Myers Squibb Co
Chia Tai Tianqing Pharmaceutical Group Co Ltd
CTx Operations Inc
CytomX Therapeutics Inc
Daiichi Sankyo Co Ltd
Eisai Co Ltd
EpiThany Inc
Exelixis Inc
F. Hoffmann-La Roche Ltd
Genentech USA Inc
GeoVax Labs Inc
Gilead Sciences Inc
Ikena Oncology Inc
Incyte Corp
Innovent Biologics Inc
Jazz Pharmaceuticals Plc
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Vcare PharmaTech Co Ltd
Johnson & Johnson
Kura Oncology Inc
Loxo Oncology Inc
MediciNova Inc
Merck & Co Inc
Mersana Therapeutics Inc
Merus NV
Novartis AG
Orion Corp
Osaka University
Plexxikon Inc
Poseida Therapeutics Inc
Puma Biotechnology Inc
QBiotics Group Ltd
Radboud University
RemeGen Co Ltd
Replimune Ltd
Shanghai Junshi Biosciences Co Ltd
Shanghai Miracogen Inc
Soricimed Biopharma Inc
Tessa Therapeutics Ltd
Virocure Inc
Virogin Biotech Ltd
Xencor Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Salivary Gland Cancer reports